ATE432981T1 - Multi-stellen-mutagenese - Google Patents

Multi-stellen-mutagenese

Info

Publication number
ATE432981T1
ATE432981T1 AT02798908T AT02798908T ATE432981T1 AT E432981 T1 ATE432981 T1 AT E432981T1 AT 02798908 T AT02798908 T AT 02798908T AT 02798908 T AT02798908 T AT 02798908T AT E432981 T1 ATE432981 T1 AT E432981T1
Authority
AT
Austria
Prior art keywords
present
transformants
mutagenesis
compositions
pef
Prior art date
Application number
AT02798908T
Other languages
English (en)
Inventor
Janice Cline
Holly Hogrefe
Original Assignee
Stratagene California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stratagene California filed Critical Stratagene California
Application granted granted Critical
Publication of ATE432981T1 publication Critical patent/ATE432981T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102Mutagenizing nucleic acids
    • C12N15/1027Mutagenizing nucleic acids by DNA shuffling, e.g. RSR, STEP, RPR
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102Mutagenizing nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241Nucleotidyltransferases (2.7.7)
    • C12N9/1252DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases RNAses, DNAses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
AT02798908T 2001-07-26 2002-07-18 Multi-stellen-mutagenese ATE432981T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30792701P 2001-07-26 2001-07-26
PCT/US2002/022759 WO2003025118A2 (en) 2001-07-26 2002-07-18 Multi-site mutagenesis

Publications (1)

Publication Number Publication Date
ATE432981T1 true ATE432981T1 (de) 2009-06-15

Family

ID=23191773

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02798908T ATE432981T1 (de) 2001-07-26 2002-07-18 Multi-stellen-mutagenese

Country Status (7)

Country Link
US (2) US8067556B2 (de)
EP (1) EP1417327B1 (de)
JP (1) JP4473573B2 (de)
AT (1) ATE432981T1 (de)
CA (1) CA2454319A1 (de)
DE (1) DE60232523D1 (de)
WO (1) WO2003025118A2 (de)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1281757A1 (de) * 2001-07-31 2003-02-05 Direvo Biotech AG Methode zur Herstellung von Nukleinsäuren mit stochastisch kombinierten Abschnitten von Ausgangsnukleinsäuren
EP1658374A4 (de) * 2003-07-29 2007-04-11 Sigma Aldrich Co Verfahren und zusammensetzungen zur amplifikation von dna
WO2006004949A1 (en) * 2004-06-30 2006-01-12 Applera Corporation Compositions and methods for detecting and quantitating polynucleotide sequences
JP2010500040A (ja) * 2006-08-15 2010-01-07 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガニゼイション 断片ライゲーションによる再構成
US20080213841A1 (en) * 2006-08-21 2008-09-04 Pondicherry Biotech Private Limited Novel Method for Assembling DNA Metasegments to use as Substrates for Homologous Recombination in a Cell
US20080124768A1 (en) * 2006-10-31 2008-05-29 Sigma Aldrich Co. Methods and Compositions for Amplification of DNA
MX353478B (es) * 2007-07-31 2018-01-15 Bp Corp North America Inc Star Ensamblaje combinacional de sitios multiples, a la medida.
US8927218B2 (en) 2011-06-27 2015-01-06 Flir Systems, Inc. Methods and compositions for segregating target nucleic acid from mixed nucleic acid samples
JP2014520530A (ja) 2011-06-27 2014-08-25 フリアー システムズ, インコーポレイテッド 混合性核酸試料からの標的核酸の隔離
CA2840542A1 (en) 2011-06-28 2013-01-03 Igor Kutyavin Methods and compositions for enrichment of nucleic acids in mixtures of highly homologous sequences
EP3613852A3 (de) 2011-07-22 2020-04-22 President and Fellows of Harvard College Beurteilung und verbesserung einer nukleasespaltungsspezifität
US9347057B2 (en) 2012-06-12 2016-05-24 The Johns Hopkins University Methods for efficient, expansive user-defined DNA mutagenesis
CN105637097A (zh) 2013-08-05 2016-06-01 特韦斯特生物科学公司 从头合成的基因文库
US9163284B2 (en) 2013-08-09 2015-10-20 President And Fellows Of Harvard College Methods for identifying a target site of a Cas9 nuclease
US9228207B2 (en) 2013-09-06 2016-01-05 President And Fellows Of Harvard College Switchable gRNAs comprising aptamers
US10077453B2 (en) 2014-07-30 2018-09-18 President And Fellows Of Harvard College CAS9 proteins including ligand-dependent inteins
CA2975855A1 (en) * 2015-02-04 2016-08-11 Twist Bioscience Corporation Compositions and methods for synthetic gene assembly
WO2016126882A1 (en) 2015-02-04 2016-08-11 Twist Bioscience Corporation Methods and devices for de novo oligonucleic acid assembly
US9834774B2 (en) 2015-02-11 2017-12-05 Agilent Technologies, Inc. Methods and compositions for rapid seamless DNA assembly
WO2016172377A1 (en) 2015-04-21 2016-10-27 Twist Bioscience Corporation Devices and methods for oligonucleic acid library synthesis
US10844373B2 (en) 2015-09-18 2020-11-24 Twist Bioscience Corporation Oligonucleic acid variant libraries and synthesis thereof
CN108698012A (zh) 2015-09-22 2018-10-23 特韦斯特生物科学公司 用于核酸合成的柔性基底
IL294014B1 (en) 2015-10-23 2024-03-01 Harvard College Nucleobase editors and their uses
CN115920796A (zh) 2015-12-01 2023-04-07 特韦斯特生物科学公司 功能化表面及其制备
US20170266218A1 (en) * 2016-03-21 2017-09-21 Steve McNerlin Nad+ coenzyme formulation and methods of making and using the same
AU2017306676B2 (en) 2016-08-03 2024-02-22 President And Fellows Of Harvard College Adenosine nucleobase editors and uses thereof
CA3033327A1 (en) 2016-08-09 2018-02-15 President And Fellows Of Harvard College Programmable cas9-recombinase fusion proteins and uses thereof
EP3500672A4 (de) 2016-08-22 2020-05-20 Twist Bioscience Corporation De-novo-synthetisierte nukleinsäure-bibliotheken
WO2018039438A1 (en) 2016-08-24 2018-03-01 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
KR102217487B1 (ko) 2016-09-21 2021-02-23 트위스트 바이오사이언스 코포레이션 핵산 기반 데이터 저장
CN110214180A (zh) 2016-10-14 2019-09-06 哈佛大学的校长及成员们 核碱基编辑器的aav递送
KR102514213B1 (ko) 2016-12-16 2023-03-27 트위스트 바이오사이언스 코포레이션 면역 시냅스의 변이체 라이브러리 및 그의 합성
WO2018119359A1 (en) 2016-12-23 2018-06-28 President And Fellows Of Harvard College Editing of ccr5 receptor gene to protect against hiv infection
SG11201907713WA (en) 2017-02-22 2019-09-27 Twist Bioscience Corp Nucleic acid based data storage
US11898179B2 (en) 2017-03-09 2024-02-13 President And Fellows Of Harvard College Suppression of pain by gene editing
JP2020510439A (ja) 2017-03-10 2020-04-09 プレジデント アンド フェローズ オブ ハーバード カレッジ シトシンからグアニンへの塩基編集因子
WO2018170169A1 (en) 2017-03-15 2018-09-20 Twist Bioscience Corporation Variant libraries of the immunological synapse and synthesis thereof
KR20190130613A (ko) 2017-03-23 2019-11-22 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 핵산 프로그램가능한 dna 결합 단백질을 포함하는 핵염기 편집제
WO2018209320A1 (en) 2017-05-12 2018-11-15 President And Fellows Of Harvard College Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation
WO2018231864A1 (en) 2017-06-12 2018-12-20 Twist Bioscience Corporation Methods for seamless nucleic acid assembly
SG11201912057RA (en) 2017-06-12 2020-01-30 Twist Bioscience Corp Methods for seamless nucleic acid assembly
US10279736B2 (en) 2017-06-29 2019-05-07 Jvis-Usa, Llc Vehicle interior trim assembly configured to form a light pattern having an emblem shape at the front of a trim part such as an air bag cover
WO2019023680A1 (en) 2017-07-28 2019-01-31 President And Fellows Of Harvard College METHODS AND COMPOSITIONS FOR EVOLUTION OF BASIC EDITORS USING PHAGE-ASSISTED CONTINUOUS EVOLUTION (PACE)
US11319532B2 (en) 2017-08-30 2022-05-03 President And Fellows Of Harvard College High efficiency base editors comprising Gam
WO2019051501A1 (en) 2017-09-11 2019-03-14 Twist Bioscience Corporation PROTEINS BINDING TO GPCR AND METHODS OF SYNTHESIS
US11795443B2 (en) 2017-10-16 2023-10-24 The Broad Institute, Inc. Uses of adenosine base editors
JP7066840B2 (ja) 2017-10-20 2022-05-13 ツイスト バイオサイエンス コーポレーション ポリヌクレオチド合成のための加熱されたナノウェル
EP3735459A4 (de) 2018-01-04 2021-10-06 Twist Bioscience Corporation Digitale informationsspeicherung auf dna-basis
KR20210013128A (ko) 2018-05-18 2021-02-03 트위스트 바이오사이언스 코포레이션 핵산 하이브리드화를 위한 폴리뉴클레오타이드, 시약 및 방법
CN113766930A (zh) 2019-02-26 2021-12-07 特韦斯特生物科学公司 Glp1受体的变异核酸文库
CA3131691A1 (en) 2019-02-26 2020-09-03 Twist Bioscience Corporation Variant nucleic acid libraries for antibody optimization
EP3942040A1 (de) 2019-03-19 2022-01-26 The Broad Institute, Inc. Verfahren und zusammensetzungen zur editierung von nukleotidsequenzen
US11332738B2 (en) 2019-06-21 2022-05-17 Twist Bioscience Corporation Barcode-based nucleic acid sequence assembly
JP2023509618A (ja) * 2019-12-30 2023-03-09 ナンジン、ジェンスクリプト、バイオテック、カンパニー、リミテッド 遺伝子変異ライブラリーを構築する方法
MX2022014008A (es) 2020-05-08 2023-02-09 Broad Inst Inc Métodos y composiciones para la edición simultánea de ambas cadenas de una secuencia de nucleótidos de doble cadena objetivo.
US20220177869A1 (en) * 2020-12-08 2022-06-09 Trustees Of Tufts College Method of generating targeted dna libraries

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5556750A (en) * 1989-05-12 1996-09-17 Duke University Methods and kits for fractionating a population of DNA molecules based on the presence or absence of a base-pair mismatch utilizing mismatch repair systems
US5494810A (en) 1990-05-03 1996-02-27 Cornell Research Foundation, Inc. Thermostable ligase-mediated DNA amplifications system for the detection of genetic disease
DE69126064T2 (de) * 1990-06-22 1997-08-28 Hoffmann La Roche Nachweis von schwachen Metabolisierungsreagentien von Drogen
US5478724A (en) * 1991-08-16 1995-12-26 The Rockefeller University Lentivirus-specific nucleotide probes and methods of use
US5436149A (en) 1993-02-19 1995-07-25 Barnes; Wayne M. Thermostable DNA polymerase with enhanced thermostability and enhanced length and efficiency of primer extension
US6165793A (en) 1996-03-25 2000-12-26 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US6063566A (en) * 1994-05-13 2000-05-16 The Scripps Research Institute Catalytic RNA molecules
US5942391A (en) * 1994-06-22 1999-08-24 Mount Sinai School Of Medicine Nucleic acid amplification method: ramification-extension amplification method (RAM)
US5965408A (en) 1996-07-09 1999-10-12 Diversa Corporation Method of DNA reassembly by interrupting synthesis
DE69934088T2 (de) * 1998-01-09 2007-06-21 University Of Utah Research Foundation, Salt Lake City Verfahren zur in vitro amplifikation zirkulärer dna
US6284461B1 (en) * 1998-04-28 2001-09-04 Aurora Biosciences Corporation Use of inhibitors in reporter assays
US6355431B1 (en) * 1999-04-20 2002-03-12 Illumina, Inc. Detection of nucleic acid amplification reactions using bead arrays
AU6385800A (en) 1999-07-30 2001-02-19 Stratagene Archaeal replication accessory factors and methods of use
AU1098001A (en) 1999-10-19 2001-04-30 Enchira Biotechnology Corporation Method for directed evolution by random chimeragenesis on transient templates
WO2001029212A1 (en) 1999-10-19 2001-04-26 Enchira Biotechnology Corporation Methods for chimeragenesis of whole genomes or large polynucleotides
US6528254B1 (en) * 1999-10-29 2003-03-04 Stratagene Methods for detection of a target nucleic acid sequence
US6221603B1 (en) * 2000-02-04 2001-04-24 Molecular Dynamics, Inc. Rolling circle amplification assay for nucleic acid analysis
JP3859947B2 (ja) 2000-08-04 2006-12-20 独立行政法人理化学研究所 突然変異導入方法
US6350580B1 (en) * 2000-10-11 2002-02-26 Stratagene Methods for detection of a target nucleic acid using a probe comprising secondary structure

Also Published As

Publication number Publication date
CA2454319A1 (en) 2003-03-27
JP2005521381A (ja) 2005-07-21
WO2003025118A2 (en) 2003-03-27
DE60232523D1 (de) 2009-07-16
EP1417327A2 (de) 2004-05-12
US20130122550A1 (en) 2013-05-16
JP4473573B2 (ja) 2010-06-02
WO2003025118A3 (en) 2003-08-14
US20060051748A1 (en) 2006-03-09
US8067556B2 (en) 2011-11-29
US8685676B2 (en) 2014-04-01
EP1417327A4 (de) 2005-11-30
EP1417327B1 (de) 2009-06-03

Similar Documents

Publication Publication Date Title
DE60232523D1 (de) Multi-stellen-mutagenese
HUP0302601A2 (hu) Mutáns allergének
PT1543117E (pt) Método de pesquisa de mutagénese de elevado rendimento
CA2158750A1 (en) Monoclonal antibodies to casein kinase i polypeptides
TW200631594A (en) Toll like receptor 3 antagonists, methods and uses
WO2002072605A3 (en) Expression technology for proteins containing a hybrid isotype antibody moiety
WO2004029219A3 (en) Cell-based rna interference and related methods and compositions
DK2202308T3 (da) Fremgangsmåder og sammensætninger til manipulation af polypeptider
DE60142614D1 (de) Inität
HUP0203064A2 (en) Granules based on starch and lactose
GB0316706D0 (en) Method of characterizing potential therapeutics by determining cell-cell interactions
DK1311670T3 (da) Fremgangsmåde til massiv dirigeret mutagenese
WO2004093908A3 (en) Compositions and methods for the therapy of inflammatory bowel disease
WO2001075178A3 (en) Methods for identifying peptide aptamers capable of altering a cell phenotype
WO2005074973A3 (en) Method of inducing or modulating immune response
EP1272609A4 (de) Einkettige antikörper gegen eine p53 mutante
WO2005072290A3 (en) Methods of treating, reducing, or preventing autoimmune conditions
MXPA03007413A (es) Composicion y metodo para tratar enfermedades inflamatorias.
EP1487854A4 (de) Neue isoformen des gefässendothel-zellwachstumshemmers
GB2387847B (en) Method for producing monoclonal antibodies
DK1259628T3 (da) Fremgangsmåde til dannelse af hypermutabel gær
WO2002004630A3 (en) Methods for recombinatorial nucleic acid synthesis
BRPI0415571A (pt) composições de limpeza
AU2003247599A1 (en) Methods of modulating cytokinin related processes in a plant using b3 domain proteins
IL153576A0 (en) Dna vaccines encoding hiv accessory proteins

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties